NIR‐II Cyanine Nanoparticles for Imaging‐Guided Tumor Targeting Photothermal Therapy with Vitamin C Enhanced Efficacy

Author:

Huang Yurou1,Ma Xiaoxie1,Li Jiang23,Tan Chunyan2,Yin Jun1ORCID

Affiliation:

1. National Key Laboratory of Green Pesticide Central China Normal University Wuhan 430079 P. R. China

2. State Key Laboratory of Chemical Oncogenomics, Tsinghua Shenzhen International Graduate School Tsinghua University Shenzhen 518055 P. R. China

3. Shenzhen Polytechnic Shenzhen 518055 P. R. China

Abstract

AbstractCyanine dyes in the near‐infrared‐II (NIR‐II) region are among the most promising photothermal agents, due to their high photothermal conversion efficiency, strong tumor targeting capability, and deep tissue penetration. The application of cyanine‐based photothermal agents remains limited, however, due to the invasive nature and spread of tumors as well as the potential for inflammatory responses during the treatment process. In this work, a naphtho[cd]indolium‐based heptamethine cyanine with NIR‐II emission is utilized to prepare PEGylated nanoparticles for studies of photothermal treatment. The results demonstrate that the nanoparticles have excellent NIR‐II imaging and tumor targeting capabilities. As a result of the light harvesting property of naphtho[cd]indolium‐based heptamethine cyanine, these nanoparticles demonstrate a photothermal conversion efficiency of 61%. The tumor‐targeting properties of these nanoparticles enable them to accumulate effectively at limbs containing tumors. Photothermal therapy shows almost complete disappearance of all tumors after eight days of treatment. In addition, hematoxylin‐eosin stains (H&E stains) of major organs show no discernible lesions throughout the treatment process. Furthermore, simultaneous injection of natural vitamin C during the treatment significantly improves the therapeutic effect of photothermal therapy.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry (medical),Genetics (clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3